Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO)
发明人:
申请号：
EP18382555.3
公开号：
EP3598973A1
申请日:
2018.07.24
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising an inhibitor of the expression, activity and/or function of c-Raf and an inhibitor of the expression, activity and/or function of EGF Receptor (EGFR) and its use in the treatment of pancreatic cancer.
